Los puntos clave no están disponibles para este artículo en este momento.
ctDNA tumor fraction to prognosticate overall survival on enzalutamide post-abiraterone by treatment arm
Sweeney et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: